awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36029760-52541DEB-373C-4AEB-82C3-2FB0A3AD1E75
Q36029760-52541DEB-373C-4AEB-82C3-2FB0A3AD1E75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36029760-52541DEB-373C-4AEB-82C3-2FB0A3AD1E75
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative On
P2860
Q36029760-52541DEB-373C-4AEB-82C3-2FB0A3AD1E75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36029760-52541DEB-373C-4AEB-82C3-2FB0A3AD1E75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a471e0ad8ad956c6a7e011a3d4687085e6fb625f
P2860
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer